Immunosuppressant drugs for myasthenia gravisI K Hart1, T Sharshar2, S Sathasivam1 1 The Walton Centre for Neurology and Neurosurgery, Liverpool, UK 2 Hôpital Raymond Poincaré, Garches, France Dr I K Hart, The Walton Centre for Neurology and Neurosurgery, Lower Lane, Liverpool L9 7LJ, UK; ian{at}kirkhart.freeserve.co.uk Abstract Along with corticosteroids, immunosuppressant drugs are mainstays of disease-modifying therapy for myasthenia grav
